# Gastric Crohn’s Disease With Ileocolonic Involvement in a Patient With Chronic Recurrent Multifocal Osteomyelitis: A Rare Case Presentation

**Authors:** Abdul Ghaffar, Fraz Ahmad, Joseph Collum, Hamid Mushtaq, Abdulrahman Abouzaid

PMC · DOI: 10.7759/cureus.84586 · Cureus · 2025-05-21

## TL;DR

This paper presents a rare case of gastric Crohn's disease in a young woman with iron deficiency anemia and ileocolonic involvement.

## Contribution

The novelty lies in the rare presentation of gastric Crohn’s disease with ileocolonic involvement in a patient with a history of chronic recurrent multifocal osteomyelitis.

## Key findings

- Gastric Crohn’s disease was diagnosed through endoscopy and biopsy findings in a patient with persistent iron deficiency anemia.
- The patient showed ileocolonic involvement with granulomas consistent with Crohn’s colitis.
- Treatment with budesonide and infliximab led to no significant relapse episodes.

## Abstract

Gastric Crohn’s disease is a rare manifestation of Crohn’s disease affecting the stomach, unlike its more common forms that primarily affect the ileum and colon. This is a case of an 18-year-old female who was referred to gastroenterology for investigation of iron deficiency anaemia, which was first noted when she was 15 years old. Investigation for persistent iron deficiency anaemia (IDA) revealed high faecal calprotectin and a positive faecal immunochemical test (FIT). Endoscopy was done, which revealed mild haemorrhagic gastritis and a few superficial gastric erosions. Biopsies taken from the gastric fundus indicated ill-defined granulomas with no significant active inflammation and no presence of Helicobacter pylori. Colonoscopy done up to the caecum was normal endoscopically. However, the random colonic biopsies taken from the ascending colon revealed mild active chronic inflammation. Granulomas were seen, in keeping with Crohn’s colitis, making this a case of gastric Crohn’s disease with ileocolonic involvement. The patient was treated with budesonide for acute symptom management. Following discussion in the inflammatory bowel disease (IBD) multi-disciplinary team meeting (MDT), she was commenced on Infliximab. Follow-up evaluations showed no significant relapse episodes. This case also highlights the importance of family history and genetic evaluation in patients with potential hereditary or autoinflammatory conditions, which would aid in narrowing the diagnostic spectrum.

## Linked entities

- **Chemicals:** budesonide (PubChem CID 5281004)
- **Diseases:** Crohn’s disease (MONDO:0005011), iron deficiency anaemia (MONDO:0001356), chronic recurrent multifocal osteomyelitis (MONDO:0009813), inflammatory bowel disease (MONDO:0005265)

## Full-text entities

- **Diseases:** IBD (MESH:D015212), Multifocal Osteomyelitis (MESH:C535456), haemorrhagic gastritis (MESH:D006470), Granulomas (MESH:D006099), IDA (MESH:D000090463), gastric erosions (MESH:D014077), Crohn's colitis (MESH:D003424), chronic inflammation (MESH:D007249)
- **Chemicals:** budesonide (MESH:D019819), Infliximab (MESH:D000069285)
- **Species:** Homo sapiens (human, species) [taxon 9606], Helicobacter pylori (species) [taxon 210]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12181399/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12181399/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12181399/full.md

---
Source: https://tomesphere.com/paper/PMC12181399